LENZ Therapeutics is a commercial pharmaceutical company focused on developing and commercializing innovative vision therapies. Its lead product, VIZZ (aceclidine ophthalmic solution 1.44%), received FDA approval on July 31, 2025, as the first and only FDA-approved aceclidine-based eye drop for presbyopia treatment. VIZZ is a once-daily drop providing up to 10 hours of near vision improvement. The company commercializes VIZZ in the U.S. and pursues international licensing and distribution partnerships globally.
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-24 | 2025-12-31 | 0001815776-26-000011 | EDGAR | 85K words |
| 2025-03-19 | 2024-12-31 | 0001815776-25-000019 | EDGAR | 112K words |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021135 | EDGAR | 103K words |
| 2023-03-20 | 2022-12-31 | 0000950170-23-008764 | EDGAR | 111K words |
| 2022-03-21 | 2021-12-31 | 0001564590-22-011123 | EDGAR | 111K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001815776-26-000052 | EDGAR | 59K words |
| 2025-11-05 | 2025-09-30 | 0001815776-25-000071 | EDGAR | 61K words |
| 2025-07-30 | 2025-06-30 | 0001815776-25-000056 | EDGAR | 62K words |
| 2025-05-07 | 2025-03-31 | 0001815776-25-000032 | EDGAR | 59K words |
| 2024-11-06 | 2024-09-30 | 0001815776-24-000071 | EDGAR | 60K words |
| 2024-08-14 | 2024-06-30 | 0001815776-24-000060 | EDGAR | 59K words |
| 2024-05-08 | 2024-03-31 | 0001815776-24-000042 | EDGAR | 58K words |
| 2023-11-13 | 2023-09-30 | 0000950170-23-062942 | EDGAR | 32K words |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042525 | EDGAR | 28K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021242 | EDGAR | 24K words |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023869 | EDGAR | 75K words |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016869 | EDGAR | 73K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001815776-26-000051 | EDGAR | 3K words |
| 2026-03-24 | 0001815776-26-000008 | EDGAR | 3K words |
| 2026-01-07 | 0001815776-26-000003 | EDGAR | 1K words |
| 2025-12-12 | 0001815776-25-000077 | EDGAR | 1K words |
| 2025-11-05 | 0001815776-25-000069 | EDGAR | 2K words |
| 2025-10-08 | 0001815776-25-000064 | EDGAR | 1K words |
| 2025-09-30 | 0001815776-25-000062 | EDGAR | 1K words |
| 2025-07-31 | 0001815776-25-000059 | EDGAR | 2K words |
| 2025-07-30 | 0001815776-25-000054 | EDGAR | 2K words |
| 2025-06-10 | 0001815776-25-000036 | EDGAR | 1K words |
91 total filings indexed. 64 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001815776 |
| Ticker | LENZ |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.lenz-tx.com |
| Listed | 2024-03-22 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LENZ (~200 tokens, structured JSON with cryptographic provenance)